# Assessment of The Efficacy of Intratympanic Platelet Rich Plasma for Treatment of Sensorineural Hearing Loss.

> **NCT05786378** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Assiut University** · enrollment: 23 (estimated)

## Conditions studied

- Hearing Loss, Sudden
- Hearing Loss, Sensorineural
- Hearing Loss

## Interventions

- **BIOLOGICAL:** Platelet Rich Plasma
- **DRUG:** local anesthesia in external auditory canal
- **PROCEDURE:** Intratympanic Injection

## Key facts

- **NCT ID:** NCT05786378
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-06-01
- **Primary completion:** 2024-01
- **Final completion:** 2024-02
- **Target enrollment:** 23 (ESTIMATED)
- **Last updated:** 2023-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05786378

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05786378, "Assessment of The Efficacy of Intratympanic Platelet Rich Plasma for Treatment of Sensorineural Hearing Loss.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05786378. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*